A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques

Abstract The recurrence of new human cases of Middle East respiratory syndrome coronavirus (MERS-CoV) underscores the need for effective therapeutic countermeasures. Nonhuman primate models are considered the gold standard for preclinical evaluation of therapeutic countermeasures. However, MERS-CoV-...

Full description

Bibliographic Details
Main Authors: Adam S. Cockrell, Joshua C. Johnson, Ian N. Moore, David X. Liu, Kevin W. Bock, Madeline G. Douglas, Rachel L. Graham, Jeffrey Solomon, Lisa Torzewski, Christopher Bartos, Randy Hart, Ralph S. Baric, Reed F. Johnson
Format: Article
Language:English
Published: Nature Portfolio 2018-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-28900-1
_version_ 1830288009756409856
author Adam S. Cockrell
Joshua C. Johnson
Ian N. Moore
David X. Liu
Kevin W. Bock
Madeline G. Douglas
Rachel L. Graham
Jeffrey Solomon
Lisa Torzewski
Christopher Bartos
Randy Hart
Ralph S. Baric
Reed F. Johnson
author_facet Adam S. Cockrell
Joshua C. Johnson
Ian N. Moore
David X. Liu
Kevin W. Bock
Madeline G. Douglas
Rachel L. Graham
Jeffrey Solomon
Lisa Torzewski
Christopher Bartos
Randy Hart
Ralph S. Baric
Reed F. Johnson
author_sort Adam S. Cockrell
collection DOAJ
description Abstract The recurrence of new human cases of Middle East respiratory syndrome coronavirus (MERS-CoV) underscores the need for effective therapeutic countermeasures. Nonhuman primate models are considered the gold standard for preclinical evaluation of therapeutic countermeasures. However, MERS-CoV-induced severe respiratory disease in humans is associated with high viral loads in the lower respiratory tract, which may be difficult to achieve in nonhuman primate models. Considering this limitation, we wanted to ascertain the effectiveness of using a MERS-CoV infectious clone (icMERS-0) previously shown to replicate to higher titers than the wild-type EMC 2012 strain. We observed respiratory disease resulting from exposure to the icMERS-0 strain as measured by CT in rhesus monkeys with concomitant detection of virus antigen by immunohistochemistry. Overall, respiratory disease was mild and transient, resolving by day 30 post-infection. Although pulmonary disease was mild, these results demonstrate for the first time the utility of CT imaging to measure disease elicited by a MERS-CoV infectious clone system in nonhuman primate models.
first_indexed 2024-12-19T04:28:05Z
format Article
id doaj.art-51deb0a819be41de97eecf54819fbc13
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T04:28:05Z
publishDate 2018-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-51deb0a819be41de97eecf54819fbc132022-12-21T20:35:58ZengNature PortfolioScientific Reports2045-23222018-07-01811910.1038/s41598-018-28900-1A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaquesAdam S. Cockrell0Joshua C. Johnson1Ian N. Moore2David X. Liu3Kevin W. Bock4Madeline G. Douglas5Rachel L. Graham6Jeffrey Solomon7Lisa Torzewski8Christopher Bartos9Randy Hart10Ralph S. Baric11Reed F. Johnson12Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel HillIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research PlazaInfectious Disease Pathogenesis Section, Comparative Medicine Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of HealthIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research PlazaInfectious Disease Pathogenesis Section, Comparative Medicine Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of HealthDepartment of Epidemiology, University of North Carolina-Chapel Hill, Chapel HillDepartment of Epidemiology, University of North Carolina-Chapel Hill, Chapel HillClinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer ResearchIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research PlazaIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research PlazaIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research PlazaDepartment of Epidemiology, University of North Carolina-Chapel Hill, Chapel HillEmerging Viral Pathogens Section, Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research PlazaAbstract The recurrence of new human cases of Middle East respiratory syndrome coronavirus (MERS-CoV) underscores the need for effective therapeutic countermeasures. Nonhuman primate models are considered the gold standard for preclinical evaluation of therapeutic countermeasures. However, MERS-CoV-induced severe respiratory disease in humans is associated with high viral loads in the lower respiratory tract, which may be difficult to achieve in nonhuman primate models. Considering this limitation, we wanted to ascertain the effectiveness of using a MERS-CoV infectious clone (icMERS-0) previously shown to replicate to higher titers than the wild-type EMC 2012 strain. We observed respiratory disease resulting from exposure to the icMERS-0 strain as measured by CT in rhesus monkeys with concomitant detection of virus antigen by immunohistochemistry. Overall, respiratory disease was mild and transient, resolving by day 30 post-infection. Although pulmonary disease was mild, these results demonstrate for the first time the utility of CT imaging to measure disease elicited by a MERS-CoV infectious clone system in nonhuman primate models.https://doi.org/10.1038/s41598-018-28900-1
spellingShingle Adam S. Cockrell
Joshua C. Johnson
Ian N. Moore
David X. Liu
Kevin W. Bock
Madeline G. Douglas
Rachel L. Graham
Jeffrey Solomon
Lisa Torzewski
Christopher Bartos
Randy Hart
Ralph S. Baric
Reed F. Johnson
A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
Scientific Reports
title A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
title_full A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
title_fullStr A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
title_full_unstemmed A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
title_short A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
title_sort spike modified middle east respiratory syndrome coronavirus mers cov infectious clone elicits mild respiratory disease in infected rhesus macaques
url https://doi.org/10.1038/s41598-018-28900-1
work_keys_str_mv AT adamscockrell aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT joshuacjohnson aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT iannmoore aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT davidxliu aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT kevinwbock aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT madelinegdouglas aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT rachellgraham aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT jeffreysolomon aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT lisatorzewski aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT christopherbartos aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT randyhart aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT ralphsbaric aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT reedfjohnson aspikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT adamscockrell spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT joshuacjohnson spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT iannmoore spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT davidxliu spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT kevinwbock spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT madelinegdouglas spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT rachellgraham spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT jeffreysolomon spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT lisatorzewski spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT christopherbartos spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT randyhart spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT ralphsbaric spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques
AT reedfjohnson spikemodifiedmiddleeastrespiratorysyndromecoronavirusmerscovinfectiouscloneelicitsmildrespiratorydiseaseininfectedrhesusmacaques